These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20569473)

  • 21. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.
    Salou M; Dagnra AY; Butel C; Vidal N; Serrano L; Takassi E; Konou AA; Houndenou S; Dapam N; Singo-Tokofaï A; Pitche P; Atakouma Y; Prince-David M; Delaporte E; Peeters M
    J Int AIDS Soc; 2016; 19(1):20683. PubMed ID: 27125320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings.
    Vitoria M; Ford N; Doherty M; Flexner C
    Antivir Ther; 2014; 19 Suppl 3():31-7. PubMed ID: 25310534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV care and treatment for children in resource-limited settings.
    Callens SF; McKellar MS; Colebunders R
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):181-90. PubMed ID: 18380600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.
    Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Prasithsirikul W; Athichathanabadi C; Likanonsakul S; Chaovavanich A
    Curr Ther Res Clin Exp; 2008 Feb; 69(1):90-100. PubMed ID: 24692786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
    Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
    J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside and nucleotide reverse transcriptase inhibitors in children.
    Giaquinto C; Rampon O; Penazzato M; Fregonese F; De Rossi A; D'Elia R
    Clin Drug Investig; 2007; 27(8):509-31. PubMed ID: 17638393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.
    Kimmel AD; Resch SC; Anglaret X; Daniels N; Goldie SJ; Danel C; Wong AY; Freedberg KA; Weinstein MC
    Cost Eff Resour Alloc; 2012 Sep; 10(1):12. PubMed ID: 22992315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
    Cleary SM; McIntyre D; Boulle AM
    Cost Eff Resour Alloc; 2006 Dec; 4():20. PubMed ID: 17147833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.
    Leisegang R; Maartens G; Hislop M; Regensberg L; Cleary S
    BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S3. PubMed ID: 20594369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries.
    Gorowara M; Burger D; Hill A; Ruxrungtham K
    Curr Opin HIV AIDS; 2010 Jan; 5(1):90-6. PubMed ID: 20046153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting.
    Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Watcharananan S; Sathapatayavongs B
    AIDS Res Ther; 2007 Nov; 4():26. PubMed ID: 18031583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.
    Gilks CF; Crowley S; Ekpini R; Gove S; Perriens J; Souteyrand Y; Sutherland D; Vitoria M; Guerma T; De Cock K
    Lancet; 2006 Aug; 368(9534):505-10. PubMed ID: 16890837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
    Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
    PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line antiretroviral drug discontinuations in children.
    Fortuin-de Smidt M; de Waal R; Cohen K; Technau KG; Stinson K; Maartens G; Boulle A; Igumbor EU; Davies MA
    PLoS One; 2017; 12(2):e0169762. PubMed ID: 28192529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
    Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
    Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in India.
    Hemanth Kumar AK; Ramachandran G; Rajasekaran S; Padmapriyadarsini C; Narendran G; Anitha S; Subramanyam S; Kumaraswami V; Swaminathan S
    Indian J Med Res; 2009 Oct; 130(4):451-7. PubMed ID: 19942751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.